BR112012021579A2 - traçador de tomografia por emissão de pósitron, composto precursor, método para preparar o composto precursor, cassete, composição radiofarmacêutica, método de formação de imagem por tomografia por emissão de pósitron, e, método para diagnose de uma condição. - Google Patents

traçador de tomografia por emissão de pósitron, composto precursor, método para preparar o composto precursor, cassete, composição radiofarmacêutica, método de formação de imagem por tomografia por emissão de pósitron, e, método para diagnose de uma condição.

Info

Publication number
BR112012021579A2
BR112012021579A2 BR112012021579-5A BR112012021579A BR112012021579A2 BR 112012021579 A2 BR112012021579 A2 BR 112012021579A2 BR 112012021579 A BR112012021579 A BR 112012021579A BR 112012021579 A2 BR112012021579 A2 BR 112012021579A2
Authority
BR
Brazil
Prior art keywords
precursor compound
positron emission
emission tomography
tracer
preparing
Prior art date
Application number
BR112012021579-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Achanath Radha
Balaji Srinath
Michael Fairway Steven
Mantzilas Dimitrios
Mokkapati Umamaheshwar
O'shea Dennis
Marie Passmore Joanna
Shan Bo
John Trigg William
John Wadsworth Harry
Mohammed Kadavilpparampu Mohamed Afsal
Original Assignee
Ge Healthcare Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2010/053998 external-priority patent/WO2010109007A2/en
Priority claimed from GBGB1015203.1A external-priority patent/GB201015203D0/en
Application filed by Ge Healthcare Limited filed Critical Ge Healthcare Limited
Publication of BR112012021579A2 publication Critical patent/BR112012021579A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nuclear Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR112012021579-5A 2010-03-26 2011-03-28 traçador de tomografia por emissão de pósitron, composto precursor, método para preparar o composto precursor, cassete, composição radiofarmacêutica, método de formação de imagem por tomografia por emissão de pósitron, e, método para diagnose de uma condição. BR112012021579A2 (pt)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EPPCT/EP2010/053998 2010-03-26
PCT/EP2010/053998 WO2010109007A2 (en) 2009-03-27 2010-03-26 Indole derivatives
IN1824/DEL/2010 2010-08-02
IN1824DE2010 2010-08-02
GBGB1015203.1A GB201015203D0 (en) 2010-03-26 2010-09-13 Active enantiomer
US12/880218 2010-09-13
GB1015203.1 2010-09-13
US12/880,218 US8501153B2 (en) 2009-03-27 2010-09-13 Active enantiomer
PCT/EP2011/054744 WO2011117421A1 (en) 2010-03-26 2011-03-28 Tricyclic indole derivatives as pbr ligands

Publications (1)

Publication Number Publication Date
BR112012021579A2 true BR112012021579A2 (pt) 2019-09-24

Family

ID=44259848

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012021579-5A BR112012021579A2 (pt) 2010-03-26 2011-03-28 traçador de tomografia por emissão de pósitron, composto precursor, método para preparar o composto precursor, cassete, composição radiofarmacêutica, método de formação de imagem por tomografia por emissão de pósitron, e, método para diagnose de uma condição.

Country Status (15)

Country Link
EP (1) EP2552891B1 (https=)
JP (1) JP5830519B2 (https=)
KR (1) KR101886879B1 (https=)
CN (1) CN102834379B (https=)
AU (1) AU2011231508B2 (https=)
BR (1) BR112012021579A2 (https=)
CA (1) CA2792394C (https=)
ES (1) ES2688574T3 (https=)
IL (1) IL221510A (https=)
MX (1) MX2012010954A (https=)
NZ (1) NZ602025A (https=)
RU (1) RU2551423C2 (https=)
SG (1) SG183837A1 (https=)
WO (1) WO2011117421A1 (https=)
ZA (1) ZA201208067B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2946159B2 (ja) 1993-04-01 1999-09-06 高浜工業株式会社 瓦焼成用のスペ−サ装着装置
GB201016038D0 (en) * 2010-09-24 2010-11-10 Ge Healthcare Ltd In vivo imaging method
GB201016411D0 (en) * 2010-09-30 2010-11-10 Ge Healthcare Ltd In vivo imaging method for cancer
KR20150088802A (ko) 2012-11-30 2015-08-03 지이 헬쓰케어 리미티드 트리시클릭 인돌 유도체의 결정화 방법
GB201312768D0 (en) * 2013-07-17 2013-08-28 Ge Healthcare Ltd Work-up procedure
GB201316764D0 (en) * 2013-09-20 2013-11-06 Ge Healthcare Ltd Novel compounds
KR102668112B1 (ko) 2014-12-04 2024-05-23 지이 헬쓰케어 리미티드 방사성 약제로부터의 아세트알데히드의 제거 방법
CN106748802B (zh) * 2016-12-26 2018-11-13 南京理工大学 一种制备含氟仲胺的方法
CN114085221B (zh) * 2021-11-29 2022-12-09 暨南大学 含氮杂环化合物、标记的含氮杂环化合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2599740B1 (fr) * 1986-06-05 1988-08-12 Rhone Poulenc Sante Derives de benzo(b)thiophene de benzo(b)furannecarboxamides, leurs procedes de preparation et les medicaments les contenant
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
US7160909B2 (en) 2001-08-09 2007-01-09 Eli Lilly And Company Cyclopenta[b]indole derivatives as sPLA2 inhibitors
GB0523506D0 (en) * 2005-11-18 2005-12-28 Hammersmith Imanet Ltd Novel in vivo imaging compounds
CN101528226B (zh) * 2006-08-24 2012-01-11 澳大利亚核科学技术组织 靶向外周苯二氮卓受体的氟化配体
GB0905328D0 (en) * 2009-03-27 2009-05-13 Ge Healthcare Ltd Indole derivatives

Also Published As

Publication number Publication date
EP2552891A1 (en) 2013-02-06
ZA201208067B (en) 2014-03-26
SG183837A1 (en) 2012-10-30
ES2688574T3 (es) 2018-11-05
IL221510A0 (en) 2012-12-02
CN102834379A (zh) 2012-12-19
CA2792394C (en) 2018-04-24
KR101886879B1 (ko) 2018-08-08
JP5830519B2 (ja) 2015-12-09
KR20130018711A (ko) 2013-02-25
AU2011231508A1 (en) 2012-10-04
NZ602025A (en) 2014-08-29
IL221510A (en) 2016-02-29
HK1179946A1 (en) 2013-10-11
WO2011117421A1 (en) 2011-09-29
MX2012010954A (es) 2012-11-23
RU2012141697A (ru) 2014-05-10
CA2792394A1 (en) 2011-09-29
AU2011231508B2 (en) 2014-07-31
CN102834379B (zh) 2014-12-24
RU2551423C2 (ru) 2015-05-27
JP2013523621A (ja) 2013-06-17
EP2552891B1 (en) 2018-08-08

Similar Documents

Publication Publication Date Title
BR112012021579A2 (pt) traçador de tomografia por emissão de pósitron, composto precursor, método para preparar o composto precursor, cassete, composição radiofarmacêutica, método de formação de imagem por tomografia por emissão de pósitron, e, método para diagnose de uma condição.
UY32037A (es) Daa-piridina
MX2013012793A (es) Aminoacidos radiomarcados para imagen de diagnostico.
MX2019009780A (es) Composiciones, metodos y sistemas para la sintesis y el uso de agentes trazadores.
MX2013010012A (es) Analogos de octreotato radiomarcado como trazadores de tomografia por emision de positrones.
NZ606466A (en) Peptide radiotracer compositions
ECSP099610A (es) Compuestos activos biológicamente marcados con fluoro-benzoilo 18f como agentes de diagnóstico por imágenes asi como precursores de benzotriazol-1-iloxi-benzoilo, 2,5-dioxo-pirrolidin-1-iloxi benzoilo y trimetilamonio benzoilo
MX2011010295A (es) Reactivos de radiomarcado y metodos.
AU2010332841A8 (en) Prostate specific membrane antigen inhibitors
BR112012027316A2 (pt) métodos para obter um traçador de tomografia por emissão de pósitron e para a preparação do composto, e, cassete
PH12013501017A1 (en) Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system
JP2013509378A5 (https=)
MX2013012795A (es) Procursores novedosos de derivados de glutamato.
WO2012040138A3 (en) Choline analogs as radiotracer
BR112013006498A2 (pt) composto
ECSP099505A (es) Marcación radioactiva por fluoración de aziridinas
GB201105445D0 (en) Radiolabelled flumazenil derivatives
BR112014015124A2 (pt) agente de imagiologia; composto; composição farmacêutica; kit; método de formação de imagens de um coração em um paciente; e kit de diagnóstico
MX340407B (es) Simplificacion de proceso para compuesto precursor.
IN2014DN06805A (https=)
MX2013010781A (es) Compuestos para usarse en formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central.
WO2009033584A3 (en) Diagnostic agents for positron emission imaging using f-18 radio-labeled amino-alcohols
WO2012040151A3 (en) Isotopic carbon choline analogs
BRPI0921795B8 (pt) inibidores radiomarcados do transportador de glicina 1 e seu uso
MX2011011191A (es) Nuevas moléculas precursoras para marcadores de pet marcados con f-18.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.